Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: 76 year old female with history of cabg in transferred from with evidence of recurrent avr/mvr and recent chest discomfort with ambulation major surgical or invasive procedure: redo sternotomy aortic valve repair #21 ce pericardial, mitral valve repair #26 annuloplasty band, aortic endarterectomy and patch. history of present illness: 76 year old female status post cabg with evidence for avr/mvr, chest discomfort after walking in mall prior to outside hospital admission. admitted on and referred to dr. for surgery. past medical history: cabg x2 , appendectomy, tah, cataract surgery, tonsillectomy niddm htn gout lymphoma in remission bilat. renal art. stenosis obesity social history: denies tobacco, alcohol, or recreational drug use family history: noncontributory physical exam: wdwn white female nad avss aa&ox3 eomi, anicteric supple without bruits b/s ctab s1/s2 abd obese scars present soft nt/nd ext + edema, at ankles pertinent results: 06:00am blood hct-32.7* 06:05am blood wbc-9.8 rbc-3.83* hgb-11.2* hct-33.6* mcv-88 mch-29.4 mchc-33.5 rdw-14.5 plt ct-239 06:00am blood pt-14.3* ptt-56.1* inr(pt)-1.4 06:05am blood glucose-94 urean-40* creat-1.4* na-140 k-3.7 cl-100 hco3-31 angap-13 06:10am blood wbc-10.4 rbc-3.68* hgb-10.6* hct-32.4* mcv-88 mch-29.0 mchc-32.9 rdw-14.5 plt ct-285 06:10am blood pt-15.8* ptt-59.6* inr(pt)-1.7 06:10am blood plt ct-285 06:10am blood glucose-107* urean-30* creat-1.4* na-141 k-4.0 cl-101 hco3-29 angap-15 01:40am blood alt-15 ast-21 ld(ldh)-215 alkphos-88 amylase-70 totbili-0.4 01:40am blood %hba1c-5.9 -done -done brief hospital course: admission date: , shortness of breath, pre-op avr/mvr discharge date: , aortic stenosis, mitral regurgitation 76 year old female admitted with the above who underwent redo sternotomy/avr/mvrepair with dr. on , she was transferred to pacu in stable condition with a-pacing at 80bpm. one unit prbc's transfused, wean epinephrine drip, lasix 40mg . on pod 2 the patient was awakened, sedatives weaned, patient extubated on early pod #2, ct's d/c'don pod #3, weaned nitroprusside. diuresis continued throughout her postop course.patient went into afib on after first degree avb. natrecor was also started briefly. amiodarone was started when she went back into aflutter. creatinine remained mildly elevated postop.coumadin and heparin were started on pod #7 for aflutter., and amiodarone was discontinued for wenckebach rhythm. seen by cardiology consult and transferred to the floor on pod #7.patient continued to improve her activity tolerance level, but still requires additional rehab. screening begun on .beta blockade started, held for bradycardia while sleeping , and restarted at low dose on . inr 1.7 on , and heparin dced. cleared for discharge on and rehab bed avail. medications on admission: lasix 40 mg daily plavix 75 mg daily lipitor 20 mg daily nexium 40 mg daily atenolol 12.5 mg daily allopurinol 100 mg daily discharge medications: 1. potassium chloride 10 meq capsule, sustained release sig: two (2) capsule, sustained release po q12h (every 12 hours). :*28 capsule, sustained release(s)* refills:*1* 2. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day) for 1 months. :*60 capsule(s)* refills:*0* 3. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). :*30 tablet, delayed release (e.c.)(s)* refills:*2* 4. albuterol 90 mcg/actuation aerosol sig: 1-2 puffs inhalation q6h (every 6 hours) as needed. :*1 * refills:*0* 5. fluticasone 110 mcg/actuation aerosol sig: two (2) puff inhalation (2 times a day). :*1 * refills:*2* 6. amlodipine 5 mg tablet sig: one (1) tablet po daily (daily). :*30 tablet(s)* refills:*2* 7. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). :*30 tablet, delayed release (e.c.)(s)* refills:*1* 8. furosemide 20 mg tablet sig: one (1) tablet po twice a day. :*14 tablet(s)* refills:*0* 9. propoxyphene n-acetaminophen 100-650 mg tablet sig: one (1) tablet po q6h (every 6 hours) as needed for pain. :*40 tablet(s)* refills:*0* 10. magnesium hydroxide 400 mg/5 ml suspension sig: thirty (30) ml po hs (at bedtime) as needed for constipation. ml(s) 11. lopressor 50 mg tablet sig: tablet tablet po twice a day. 12. lipitor 20 mg tablet sig: one (1) tablet po once a day. :*30 tablet(s)* refills:*2* 13. warfarin 5 mg tablet sig: one (1) tablet po once (once) for 1 doses: today only; further dosing by inr/rehab md. :*1 tablet(s)* refills:*0* discharge disposition: extended care facility: - discharge diagnosis: s/p redo avr/mvrepair/ aortic endarterectomy niddm htn cad as gout lymphoma (remission) bil renal art. stenoses aflutter/fib discharge condition: stable discharge instructions: no lotions , creams or powders on incisions may shower and pat wounds dry no driving for one month no lifting greater than 10 pounds for 10 months followup instructions: see dr. in weeks see dr. in weeks follow- up with dr. in the office in 4 weeks () goal inr 2.0-2.5- coumadind dosing after and inr followup by rehab md procedure: extracorporeal circulation auxiliary to open heart surgery diagnostic ultrasound of heart open and other replacement of aortic valve with tissue graft transfusion of packed cells open heart valvuloplasty of mitral valve without replacement endarterectomy, aorta injection or infusion of nesiritide procedure on single vessel diagnoses: esophageal reflux unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atherosclerosis of aorta gout, unspecified atrial fibrillation aortocoronary bypass status rheumatic heart failure (congestive) other malignant lymphomas, unspecified site, extranodal and solid organ sites atherosclerosis of renal artery mitral valve insufficiency and aortic valve stenosis obesity, unspecified first degree atrioventricular block 

Answer: The patient is high likely exposed to